-
AI to be most transformative technology for pharma, finds survey
europeanpharmaceuticalreview
February 01, 2021
A new report suggests artificial intelligence (AI) will be the most disruptive technology in the pharmaceutical industry this year and beyond.
-
AI to be most disruptive technology across pharma industry in 2021 and beyond
expresspharma
January 25, 2021
GlobalData analysis shows that while four partnerships were forged between AI vendors and large pharma companies in 2015, they rose to 27 by 2020, an increase of 575 per cent in just six years.
-
CES 2021 Taiwan, Chinaese biotech startup mProbe CADx develops AI health analysis platform
prnasia
January 13, 2021
mProbe Taiwan, China is a subsidiary biotechnology company of mProbe Inc, committed to promoting human health and wellness by transforming the field of precision health and precision medicine.
-
Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system to discover novel compounds for neurodegenerative diseases
prnasia
December 30, 2020
Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's novel generative artificial intelligence (AI) technology to accelerate the discovery of next generation ...
-
Bayer inks deal with Blackford Analysis to develop radiology AI platform
pharmatimes
December 03, 2020
German pharma company Bayer has signed an agreement with Scottish artificial intelligence (AI) specialist Blackford Analysis to develop an AI platform for medical imaging.
-
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
prnasia
October 14, 2020
A recent study published in JAMA Network Open has shown that an AI algorithm trained to detect pulmonary nodules can improve lung cancer detection on chest radiographs.
-
Nvidia partners with GSK’s AI lab for drug discovery
pharmaceutical-technology
October 10, 2020
US-based chipmaker Nvidia has entered into a partnership with GlaxoSmithKline (GSK) and its artificial intelligence (AI) group for the discovery of drugs and vaccines.
-
XtalPi raises $318m to support AI-based drug discovery
pharmaceutical-technology
October 09, 2020
Artificial intelligence (AI)-based drug discovery company XtalPi has raised $318.8m in a Series C funding round co-led by SoftBank Vision Fund 2, PICC Capital and Morningside.
-
Sartorius Joins DFKI to Support AI for Advanced Medicines
contractpharma
September 27, 2020
Conducting research on deep learning algorithms for modeling of biological systems and for optimization of biopharmaceutical production processes.
-
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData
expresspharma
August 19, 2020
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical trials and final drug authorization.